Mohamad Makhzoumi
CIK 1630226 · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BHG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRRO | 10%+ Owner | 1,297,893 | $12.02 | $15.60M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 5,097,538 | $29.91 | $152.47M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 1,527,217 | $16.35 | $24.97M | $35.00M | 10 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | Director | 1,354,465 | $6.75 | $9.15M | $0 | 4 | 2025-05-15 |
| MBX | 10%+ Owner | 1,023,103 | $50.29 | $51.45M | $8.00M | 1 | 2024-09-17 |
| SVRA | 10%+ Owner | 24,471,264 | $4.52 | $110.61M | $1000.0K | 1 | 2023-07-19 |
| MIRM | 10%+ Owner | 2,186,243 | $83.27 | $182.05M | $6.75M | 2 | 2023-06-15 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 30,283 | $115.07 | $3.48M | -$5.5K | 1 | 2022-12-22 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 0 | $13.29 | $0 | $10.00M | 2 | 2022-12-02 |
| IONQ.WS | 10%+ Owner | 14,616,483 | $33.55 | $490.38M | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 913 | $15.00 | $13.7K | $18.85M | 12 | 2022-10-21 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 0 | $0.00 | $0 | $21.03M | 4 | 2022-05-26 |
| HOOD | Director | 6,371 | $92.84 | $591.5K | -$49.2K | 5 | 2022-05-04 |
| TRVI | 10%+ Owner | 948,948 | $12.51 | $11.87M | $31.80M | 4 | 2022-04-13 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 2,563,257 | $0.49 | $1.27M | $9.51M | 2 | 2021-12-27 |
| GLUE | 10%+ Owner | 5,973,296 | $10.48 | $62.60M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 208 | $4.96 | $1.0K | $0 | 1 | 2021-06-10 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 1,514 | $2.57 | $3.9K | $5.59M | 2 | 2021-05-26 |
| MRKR | 10%+ Owner | 1,071,428 | $0.91 | $971.1K | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,437,689 | $4.00 | $9.75M | $4.00M | 1 | 2020-07-28 |
| NKTX | 10%+ Owner | 2,235,449 | $1.83 | $4.09M | $12.00M | 1 | 2020-07-16 |
| ARDX | 10%+ Owner | 3,482,186 | $3.00 | $10.45M | $0 | 1 | 2019-12-09 |
Recent Filings · Page 3 of 7
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Other (J) | −3,952,044 | $0 | EDGAR |
| 2022-10-19 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Sell (S) | −10,376,936 | -$750.7K | EDGAR |
| 2022-05-17 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-04 | HOOD | Mixed | −23,819,826 | -$19.6K | EDGAR |
| 2022-04-13 | TRVI | Buy (P) | +3,580,526 | $6.80M | EDGAR |
| 2022-02-01 | HOOD | Mixed | −23,863,239 | -$29.6K | EDGAR |
| 2022-01-05 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-27 | Metacrine, Inc. (MTCR) Delisted | Sell (S) | −497,270 | -$494.5K | EDGAR |
| 2021-11-12 | HOOD | Other (J) | −1,427,856 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.